Dr. Tu Dinh Dan, MD

Dr. Dan practices at William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System.

Dr. Dan's NPI, 1902192123, was assigned on June 27, 2011. Dr. Dan graduated from University Of Florida College Of Medicine in 2011. Dr. Dan's Texas license number on file is Q9981.

Dr. Dan's primary practice is William P. Clements Jr. University Hospital, at 6201 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 633-5555.

Dr. Dan's primary practice is William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Dan to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dan practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Dan's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Dan is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Dan's licenses on file in 3 states: Texas, Delaware and Pennsylvania.

Dmand AI lists bone cancer radiation, brain cancer radiation, brain tumor radiation, colorectal cancer radiation and lung cancer radiation among the conditions Dr. Dan treats.

CMS data shows 1,113 Medicare services from Dr. Dan across 13 procedure codes in 2024, for 120 Medicare patients. Medicare paid $78,707 for them.

CMS counts 120 Medicare patients who saw Dr. Dan in 2024. The largest group is 65 to 74, with 73 patients. 75% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dan's median patient age at 61, with 53% women.

In 2024, Dr. Dan wrote 229 Medicare Part D claims for 84 patients. 100% of them were for generic drugs. CMS names the drug for 118 of them, across 3 drugs with 11 or more claims each, at $1,224 in total drug cost. In 2023, CMS named 62 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Dan for performance year 2024, reported as part of a group. Dr. Dan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dan as offering telehealth.

Dmand AI links 47 papers to Dr. Dan, published from 2011 to 2025. 2022 was the busiest year, with 6. The most frequent topics are Brain Neoplasms, Radiosurgery and Antineoplastic Agents. Dr. Dan has published most often in Int J Radiat Oncol Biol Phys. Dr. Dan's most frequent co-authors are Robert Dale Timmerman, MD, Toral R. Patel, MD and Joshua D. Palmer, MD.

Dmand AI links Dr. Dan to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Brain Neoplasms and Central Nervous System Neoplasms.

CMS Open Payments shows 4 general payments to Dr. Dan from 3 drug and device companies from 2019 to 2024. Travel and lodging make up the largest share, 61% of the total. Varian Medical Systems, Inc. paid the most, $433.

Dr. Dan graduated from University Of Florida College Of Medicine in 2011.

Dr. Dan is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.